Royal Bank of Canada Has $66.44 Million Position in Relx Plc (NYSE:RELX)

Royal Bank of Canada grew its holdings in Relx Plc (NYSE:RELX) by 0.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,462,786 shares of the technology company’s stock after purchasing an additional 3,439 shares during the period. Royal Bank of Canada’s holdings in Relx were worth $66,440,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Redwood Investments LLC purchased a new stake in Relx in the 4th quarter worth about $120,000. Quantinno Capital Management LP increased its holdings in shares of Relx by 11.4% in the 4th quarter. Quantinno Capital Management LP now owns 171,219 shares of the technology company’s stock valued at $7,777,000 after purchasing an additional 17,543 shares during the period. Pathstone Holdings LLC lifted its position in shares of Relx by 0.8% in the fourth quarter. Pathstone Holdings LLC now owns 186,999 shares of the technology company’s stock worth $8,493,000 after purchasing an additional 1,433 shares in the last quarter. Lazard Asset Management LLC boosted its holdings in shares of Relx by 1.2% during the fourth quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company’s stock worth $191,868,000 after purchasing an additional 48,793 shares during the period. Finally, JARISLOWSKY FRASER Ltd boosted its holdings in shares of Relx by 3.2% during the fourth quarter. JARISLOWSKY FRASER Ltd now owns 1,202,753 shares of the technology company’s stock worth $54,629,000 after purchasing an additional 36,867 shares during the period. Institutional investors and hedge funds own 15.02% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on RELX shares. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a research report on Friday, March 14th. The Goldman Sachs Group initiated coverage on Relx in a research report on Wednesday, March 26th. They set a “buy” rating for the company. StockNews.com lowered Relx from a “buy” rating to a “hold” rating in a research report on Tuesday, March 4th. Finally, Morgan Stanley reaffirmed an “overweight” rating on shares of Relx in a research note on Wednesday, April 16th. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy”.

Relx Stock Down 0.1%

Shares of RELX stock opened at $54.97 on Wednesday. Relx Plc has a 12 month low of $43.28 and a 12 month high of $55.21. The firm has a market cap of $101.47 billion, a PE ratio of 29.55, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. The stock has a 50 day moving average of $51.43 and a 200-day moving average of $49.02. The company has a quick ratio of 0.47, a current ratio of 0.52 and a debt-to-equity ratio of 1.46.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.